Navigation Links
The Society for Melanoma Research and Prova Education Collaborate to Expand the 10th Anniversary Congress
Date:11/15/2013

Philadelphia, PA (PRWEB) November 15, 2013

More than 650 health care professionals are expected to attend the 10th Anniversary Society for Melanoma Research (SMR) Congress to learn about cutting edge research and advances in clinical care for melanoma. SMR, an international society of melanoma researchers and clinicians dedicated to finding better diagnostic and treatment options, will partner again with Prova Education, a medical education company with an expertise in cancer education, to host one of the largest annual symposia in the melanoma research community. The SMR 2013 Congress will return to Philadelphia, Pennsylvania—where the first SMR Congress was held ten years ago—at the Philadelphia Marriott Downtown on November 17 through November 20, 2013.

“We are excited to host researchers and clinicians from around the world for the 10th year in a row. They are at the forefront in their field, and their information will be invaluable to all those working to diagnose and treat melanoma,” said Meenhard Herlyn, DVM, the Wistar Institute and one of The Congress organizers. “We are delighted that Prova Education will support us again this year to spread awareness and educate other clinicians on the exciting, new research shared at this congress.”

According to the American Cancer Society, more than 75,000 people will be diagnosed with melanoma in the United States in 2013 and the cancer will claim close to 9,500 people with melanoma this year. “Through the education opportunities at the 2013 SMR Congress, we hope to extend the lives of people with melanoma. We are developing newer and better treatment options,” said Boris C. Bastian, MD, President of SMR and Professor of Cancer Biology at the University of California, San Francisco. “This Congress will address the emergent targeted and immunotherapies that have the potential to supplant existing chemotherapy treatments.”

“Prova Education is excited to support this important event for the second year in a row,” said Alana Brody, Vice President of Oncology Education Development at Prova Education. “We understand oncology, and we want to help groups like SMR provide a world-wide audience of medical professionals with the latest information on melanoma research.” Like last year, Prova Education plans to utilize on-demand, online, and on-air resources—such as ReachMD Radio, a radio broadcast station with a medical-education focus—to reach clinicians from around the globe with updates from the SMR 2013 Congress.

About the Society for Melanoma Research (SMR)
The SMR brings together myriad professionals who share an abiding devotion to sharing research to improve the lives of those suffering from melanoma. SMR focuses on bringing discoveries from bench to bedside and back by fostering cooperation between labs and clinics. It builds multidisciplinary collaborations to achieve its goals and provides yearly Congresses, ongoing workshops, and other educational opportunities that act as catalysts to raise awareness in melanoma research and clinical practice. More information is available at http://www.SocietyMelanomaResearch.org.

About Prova Education
Prova Education, a wholly owned subsidiary of US HealthConnect Inc., delivers integrated, lifelong learning opportunities that lead to improvements in clinician competence and performance, with the aim of improving patient outcomes. Its multi-platform educational network includes live meetings, online activities, social media, radio broadcasts, print media, and more. Its global footprint includes educational endeavors and strategic partnerships in North America, South America. More information is available at http://www/ProvaEducation.com.

Read the full story at http://www.prweb.com/releases/Prova/SMR/prweb11338639.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
4. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
5. Monsanto Declared Worst Company of 2011 by NaturalSociety
6. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
7. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
8. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
9. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
10. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
11. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... ... 17, 2017 , ... G-CON Manufacturing, Inc., the leader in ... Jornitz, was recognized as a Top 10 Industry Influencer on The Medicine Maker’s ... bettering the pharma industry and bringing life-changing medicines to market” across four categories. ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... When James Sherley, was notified earlier this ... Most Valuable Brands for the Year 2017 by The Silicon Review , he was ... making good progress increasing Asymmetrex’s value, but this recognition by Silicon Valley was particularly meaningful. ...
(Date:5/16/2017)... ... May 16, 2017 , ... ... Hi-C metagenomic deconvolution service. ProxiMeta enables researchers to obtain complete, distinct genomes ... insights at lower cost. , “We’re very excited about the commercial launch ...
(Date:5/16/2017)... ... May 16, 2017 , ... ... diagnostics, has released its ClearID Lung Cancer blood test. Leveraging a highly-sensitive next-generation ... new test is designed to quickly and accurately identify tumor-related genetic mutations that ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
Breaking Biology News(10 mins):